Canada Markets open in 5 hrs 31 mins

Greenwich LifeSciences, Inc. (GLSI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
8.95+0.22 (+2.52%)
At close: 04:00PM EDT
8.71 -0.24 (-2.68%)
After hours: 04:55PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 340.25
52 Week Low 36.82
50-Day Moving Average 39.17
200-Day Moving Average 314.75

Share Statistics

Avg Vol (3 month) 3236.63k
Avg Vol (10 day) 349.43k
Shares Outstanding 513.12M
Implied Shares Outstanding 6N/A
Float 8904.17k
% Held by Insiders 183.26%
% Held by Institutions 17.35%
Shares Short (Jul 14, 2022) 4418.36k
Short Ratio (Jul 14, 2022) 40.68
Short % of Float (Jul 14, 2022) 413.39%
Short % of Shares Outstanding (Jul 14, 2022) 43.27%
Shares Short (prior month Jun 14, 2022) 4366.99k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-14.91%
Return on Equity (ttm)-24.13%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -5.98M
Net Income Avi to Common (ttm)-5.94M
Diluted EPS (ttm)-0.27
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.74M
Total Cash Per Share (mrq)1.52
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)81.86
Book Value Per Share (mrq)2.19

Cash Flow Statement

Operating Cash Flow (ttm)-5.71M
Levered Free Cash Flow (ttm)-3.51M